JO2031B1 - Invention title: - Google Patents
Invention title:Info
- Publication number
- JO2031B1 JO2031B1 JO19982031A JOP19982031A JO2031B1 JO 2031 B1 JO2031 B1 JO 2031B1 JO 19982031 A JO19982031 A JO 19982031A JO P19982031 A JOP19982031 A JO P19982031A JO 2031 B1 JO2031 B1 JO 2031B1
- Authority
- JO
- Jordan
- Prior art keywords
- tetrahydropyridine
- tetrazol
- ethyl
- methyl
- acid addition
- Prior art date
Links
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 2
- 229960004373 acetylcholine Drugs 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- RNMOMKCRCIRYCZ-UHFFFAOYSA-N Alvameline Chemical compound CCN1N=NC(C=2CN(C)CCC=2)=N1 RNMOMKCRCIRYCZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
- 230000003551 muscarinic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO2031B1 true JO2031B1 (en) | 1999-05-15 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JO19982031A JO2031B1 (en) | 1997-07-01 | 1998-06-25 | Invention title: |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (fr) |
| JP (1) | JP2002507215A (fr) |
| KR (1) | KR20010014297A (fr) |
| CN (1) | CN1261361A (fr) |
| AR (1) | AR013096A1 (fr) |
| AU (1) | AU735751B2 (fr) |
| BG (1) | BG103933A (fr) |
| BR (1) | BR9810331A (fr) |
| CA (1) | CA2293324A1 (fr) |
| CO (1) | CO4940483A1 (fr) |
| EA (1) | EA200000081A1 (fr) |
| HU (1) | HUP0002876A2 (fr) |
| IL (1) | IL133093A0 (fr) |
| IS (1) | IS5278A (fr) |
| JO (1) | JO2031B1 (fr) |
| MA (1) | MA25138A1 (fr) |
| NO (1) | NO996580L (fr) |
| PE (1) | PE116099A1 (fr) |
| PL (1) | PL337184A1 (fr) |
| SK (1) | SK187399A3 (fr) |
| TN (1) | TNSN98120A1 (fr) |
| TR (1) | TR199903283T2 (fr) |
| UY (2) | UY25069A1 (fr) |
| WO (1) | WO1999001448A1 (fr) |
| ZA (1) | ZA985498B (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| HUP9901051A2 (hu) * | 1995-11-06 | 2000-03-28 | H. Lundbeck A/S | 5-(2-Etil-2H-tetrazol-5-il)-1,2,3,6-tetrahidro-1-metil-piridin alkalmazása traumás agykárosodások kezelésére alkalmas gyógyászati készítmények előállítására |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 CA CA002293324A patent/CA2293324A1/fr not_active Abandoned
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/fr not_active Ceased
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Ceased
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/fr not_active Withdrawn
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL133093A0 (en) | 2001-03-19 |
| AU735751B2 (en) | 2001-07-12 |
| CA2293324A1 (fr) | 1999-01-14 |
| BG103933A (en) | 2000-07-31 |
| HUP0002876A2 (hu) | 2001-06-28 |
| MA25138A1 (fr) | 2001-04-02 |
| NO996580D0 (no) | 1999-12-30 |
| UY25177A1 (es) | 2000-12-29 |
| UY25069A1 (es) | 1998-12-21 |
| EA200000081A1 (ru) | 2000-08-28 |
| NO996580L (no) | 1999-12-30 |
| BR9810331A (pt) | 2000-09-05 |
| CO4940483A1 (es) | 2000-07-24 |
| WO1999001448A1 (fr) | 1999-01-14 |
| CN1261361A (zh) | 2000-07-26 |
| TR199903283T2 (xx) | 2000-06-21 |
| AU8102098A (en) | 1999-01-25 |
| ZA985498B (en) | 1999-01-20 |
| IS5278A (is) | 1999-11-30 |
| SK187399A3 (en) | 2000-06-12 |
| KR20010014297A (ko) | 2001-02-26 |
| PE116099A1 (es) | 1999-11-23 |
| PL337184A1 (en) | 2000-08-14 |
| EP0994869A1 (fr) | 2000-04-26 |
| TNSN98120A1 (fr) | 2005-03-15 |
| AR013096A1 (es) | 2000-12-13 |
| JP2002507215A (ja) | 2002-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2198238A1 (fr) | Derives de la piperidine, antagonistes de la neurokinine | |
| EP0896533A4 (fr) | Pentafluorobenzenesulfonamides et analogues | |
| GEP20043303B (en) | Polycycloalkylpurines as Adenosine Receptor Antagonists | |
| WO2000047568A3 (fr) | Nouvelles benzothiazepines-1,2 presentant une activite d'inhibition de transport d'acide biliaire ileal et d'absorption de taurocholate | |
| BG103297A (en) | Aralkyl and aralkyliden heterocyclic lactams and imides | |
| NZ329627A (en) | 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones | |
| MX9605741A (es) | Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano. | |
| CA2090220A1 (fr) | Traitement des troubles intestinaux non inflammatoires et non infectieux | |
| HUT71550A (en) | Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis | |
| TR200101962T2 (tr) | Sindirim sistemi bozukluklarını tedavi etmek için 4-(aminometil)-piperidin benzamidler | |
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| DZ2141A1 (fr) | Procédés intermédiares pour la préparation de 1-benzyl-4-(5,6-diméthoxy-1-indanone)-2-yi)méthylpipéridine. | |
| CA2132544A1 (fr) | Antagonistes d'angiotensine ii utiles contre les troubles lies a une vitesse alteree de l'influx nerveux, particulierement dans le cas de la neuropathie diabetique | |
| WO1999006388A8 (fr) | COMPOSES PHARMACEUTIQUES ISOLES A PARTIR DE L'$i(ARISTOLOCHIA TALISCANA) | |
| WO2001010408A3 (fr) | Composition pharmaceutique aqueuse a base de moxifloxacine ou de ses sels | |
| CA2235747A1 (fr) | Utilisation de la 1-(2-napht-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique | |
| WO1996022305A3 (fr) | Peptides modifies | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| CA2296560A1 (fr) | Derives d'acides amines pour le traitement des accidents cerebrovasculaires | |
| BR9811821A (pt) | 2-acilaminopropanaminas como antagonistas de receptores de taquicinina | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| WO1996031208A3 (fr) | Utilisation de composes de piperidine ou de pyrrolidine substitues pour le traitement de maladies modulees par un recepteur sigma | |
| WO2002005801A3 (fr) | Compositions pharmaceutiques et procedes d'utilisation de ces dernieres | |
| NZ220195A (en) | 2-pyridyl-penem derivatives and pharmaceutical compositions | |
| JO2031B1 (en) | Invention title: |